EPIQ PARTNERS, LLC - CONMED CORP ownership

CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 260 filers reported holding CONMED CORP in Q2 2023. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
EPIQ PARTNERS, LLC ownership history of CONMED CORP
ValueSharesWeighting
Q3 2023$1,055,194
-25.8%
10,4630.0%0.80%
-17.4%
Q2 2023$1,421,817
+30.8%
10,4630.0%0.96%
+28.7%
Q1 2023$1,086,687
+17.2%
10,4630.0%0.75%
+21.6%
Q4 2022$927,440
+10.5%
10,4630.0%0.62%
+18.9%
Q3 2022$839,000
-16.3%
10,4630.0%0.52%
-15.5%
Q2 2022$1,002,000
-35.5%
10,4630.0%0.61%
-26.6%
Q1 2022$1,554,000
+4.8%
10,4630.0%0.84%
+5.8%
Q4 2021$1,483,000
+8.3%
10,4630.0%0.79%
+25.2%
Q3 2021$1,369,00010,4630.63%
Other shareholders
CONMED CORP shareholders Q2 2023
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 310,392$34,764,0004.40%
Iron Triangle Partners LP 148,317$16,612,0002.15%
Ranger Investment Management 294,664$33,002,0001.74%
Penn Capital Management Company, LLC 86,810$9,723,0001.23%
EARNEST PARTNERS LLC 1,575,336$176,438,0001.22%
Champlain Investment Partners, LLC 1,692,014$189,506,0001.09%
MOODY ALDRICH PARTNERS LLC 59,005$6,609,0001.07%
Hood River Capital Management LLC 232,412$26,030,0000.86%
OAK RIDGE INVESTMENTS LLC 80,775$9,047,0000.80%
Huber Capital Management LLC 18,620$2,085,0000.68%
View complete list of CONMED CORP shareholders